• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Potential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: A case report and review of the literature.

作者信息

Mondia Mark Willy L, Batchala Prem P, Purow Benjamin W

机构信息

Division of Neuro-Oncology, Department of Neurology, University of Virginia, Charlottesville, Virginia, USA.

Division of Nuclear Medicine, Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, Virginia, USA.

出版信息

Neurooncol Adv. 2025 May 17;7(1):vdaf096. doi: 10.1093/noajnl/vdaf096. eCollection 2025 Jan-Dec.

DOI:10.1093/noajnl/vdaf096
PMID:40584433
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12202147/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/648579dabf5d/vdaf096_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/d47ba99bb673/vdaf096_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/bd2323ff10cb/vdaf096_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/648579dabf5d/vdaf096_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/d47ba99bb673/vdaf096_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/bd2323ff10cb/vdaf096_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321e/12202147/648579dabf5d/vdaf096_fig3.jpg

相似文献

1
Potential synergism of abemaciclib with chloroquine and disulfiram/copper in atypical meningioma: A case report and review of the literature.阿贝西利与氯喹及双硫仑/铜在非典型脑膜瘤中的潜在协同作用：一例报告及文献综述
Neurooncol Adv. 2025 May 17;7(1):vdaf096. doi: 10.1093/noajnl/vdaf096. eCollection 2025 Jan-Dec.
2
Radiation recall dermatitis induced by abemaciclib with successful rechallenge: a case series and literature review.阿贝西利引起的放射性回忆性皮炎并成功再次激发：病例系列及文献综述
Breast Cancer Res Treat. 2025 Jul;212(2):189-193. doi: 10.1007/s10549-025-07712-8. Epub 2025 May 14.
3
Radiotherapy as an adjuvant in the management of intracranial meningiomas: are we practising evidence-based medicine?放射治疗作为颅内脑膜瘤治疗的辅助手段：我们是在践行循证医学吗？
Br J Neurosurg. 2008 Aug;22(4):520-8. doi: 10.1080/02688690802308687.
4
Prognostic models for progression-free survival in atypical meningioma: Comparison of machine learning-based approach and the COX model in an Asian multicenter study.非典型脑膜瘤无进展生存期的预后模型：亚洲多中心研究中基于机器学习的方法与COX模型的比较
Radiother Oncol. 2025 Feb;203:110695. doi: 10.1016/j.radonc.2024.110695. Epub 2024 Dec 19.
5
Endoscopic endonasal approach for resection of a recurrent spheno-orbital meningioma resulting in complete resolution of visual symptoms: A case report and review of literature.内镜经鼻入路切除复发性蝶眶脑膜瘤导致视力症状完全缓解：病例报告及文献复习。
J Neurooncol. 2022 Dec;160(3):545-553. doi: 10.1007/s11060-022-04141-1. Epub 2022 Nov 29.
6
Simultaneous surgical management of a giant tuberculum sellae meningioma and pregnancy-related complications: a case report and literature review.巨大鞍结节脑膜瘤与妊娠相关并发症的同期手术治疗：一例报告及文献综述
Front Oncol. 2025 Jun 4;15:1576797. doi: 10.3389/fonc.2025.1576797. eCollection 2025.
7
Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon.阿贝西利治疗激素受体阳性/人表皮生长因子受体2阴性局部晚期或转移性乳腺癌的模式及疗效：科威特和黎巴嫩的一项真实世界研究
Front Oncol. 2025 Jun 17;15:1437380. doi: 10.3389/fonc.2025.1437380. eCollection 2025.
8
Exploiting mitochondrial dysfunction to overcome BRAF inhibitor resistance in advanced melanoma: the role of disulfiram as a copper ionophore.利用线粒体功能障碍克服晚期黑色素瘤对BRAF抑制剂的耐药性：双硫仑作为铜离子载体的作用
Cell Death Dis. 2025 Jul 1;16(1):482. doi: 10.1038/s41419-025-07766-y.
9
Atypical and anaplastic meningiomas in the later decades of life: A national cancer database analysis.生命后期的非典型性和间变性脑膜瘤：国家癌症数据库分析。
Acta Neurochir (Wien). 2024 Jul 5;166(1):282. doi: 10.1007/s00701-024-06157-0.
10
Pediatric intraparenchymal meningioma in the basal ganglia treated with gross total resection: a case report and review of the literature.儿童基底节区脑实质脑膜瘤行大体全切除治疗：病例报告及文献复习。
Childs Nerv Syst. 2023 Dec;39(12):3595-3600. doi: 10.1007/s00381-023-06056-2. Epub 2023 Jun 27.

本文引用的文献

1
Benchmarking the efficacy of salvage systemic therapies for recurrent meningioma: A RANO group systematic review and meta-analysis to guide clinical trial design.复发性脑膜瘤挽救性全身治疗疗效的基准研究：RANO组的系统评价和荟萃分析以指导临床试验设计
Neuro Oncol. 2025 Sep 8;27(7):1670-1685. doi: 10.1093/neuonc/noaf009.
2
Tumor biomarkers for diagnosis, prognosis and targeted therapy.肿瘤标志物用于诊断、预后和靶向治疗。
Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2.
3
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.
靶向 RAS/RAF/MAPK 通路治疗癌症：从机制到临床研究。
Signal Transduct Target Ther. 2023 Dec 18;8(1):455. doi: 10.1038/s41392-023-01705-z.
4
Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems.利用铜/双硫仑纳米药物和药物递送系统推进癌症治疗
Pharmaceutics. 2023 May 23;15(6):1567. doi: 10.3390/pharmaceutics15061567.
5
Management of Atypical and Anaplastic Meningiomas.非典型和间变性脑膜瘤的治疗管理。
Neurosurg Clin N Am. 2023 Jul;34(3):437-446. doi: 10.1016/j.nec.2023.02.011. Epub 2023 Apr 18.
6
The Role of Pharmacotherapy in Treatment of Meningioma: A Systematic Review.药物治疗在脑膜瘤治疗中的作用：一项系统评价
Cancers (Basel). 2023 Jan 12;15(2):483. doi: 10.3390/cancers15020483.
7
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.一项关于贝伐单抗治疗复发性和难治性脑膜瘤的多机构II期试验。
Neurooncol Adv. 2022 Aug 19;4(1):vdac123. doi: 10.1093/noajnl/vdac123. eCollection 2022 Jan-Dec.
8
Emerging systemic treatment options in meningioma.脑膜瘤的新兴系统治疗选择。
J Neurooncol. 2023 Jan;161(2):245-258. doi: 10.1007/s11060-022-04148-8. Epub 2022 Oct 1.
9
CDK 4/6 inhibitors for the treatment of meningioma.用于治疗脑膜瘤的细胞周期蛋白依赖性激酶4/6抑制剂
Front Oncol. 2022 Jul 22;12:931371. doi: 10.3389/fonc.2022.931371. eCollection 2022.
10
Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.脑膜瘤 DNA 甲基化组鉴定出生物学驱动因素和治疗脆弱性。
Nat Genet. 2022 May;54(5):649-659. doi: 10.1038/s41588-022-01061-8. Epub 2022 May 9.